The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007)

被引：60
|
作者：
Gil-Prieto, Ruth [1 ]
Garcia-Garcia, Laura [1 ]
Alvaro-Meca, Alejandro [1 ]
Mendez, Cristina [2 ]
Garcia, Ana [2 ]
Gil de Miguel, Angel [1 ]
机构：
[1] Rey Juan Carlos Univ, Dept Prevent Med & Publ Hlth & Med Immunol & Micr, Madrid 28922, Alcorcon, Spain
[2] Pfizer, Dept Med, Madrid, Spain
来源：
VACCINE | 2011年 / 29卷 / 03期
关键词：
Hospitalisations; Pneumococcal pneumonia; CAP; POPULATION; EPIDEMIOLOGY; OLDER;
D O I：
10.1016/j.vaccine.2010.11.025
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
All hospital discharges and deaths related to CAP and pneumococcal-pneumonia from adults over 50 from 2003 to 2007 in Spain were obtained. Among the 447,670 Pneumonia-all causes discharges 17% were pneumococcal pneumonia. The annual hospitalisation rate was 6.27 and 1.09 cases per 1000, respectively. 75,932 deaths for Pneumonia-all causes and 9062 for pneumococcal-pneumonia were reported. CAP and pneumococcal pneumonia are major causes of morbidity and mortality in Spain, especially in the elderly. Despite current preventive measures, no significant changes in hospitalisation, mortality and case-fatality rates were found over the study period. Future preventive measures, like vaccination, could overcome these limitations. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码：412 / 416
页数：5
相关论文
共 50 条
  • [21] Characteristics of patients with community-acquired pneumococcal pneumonia
    Padiglione, AA
    Willis, J
    Bailey, M
    Fairley, CK
    MEDICAL JOURNAL OF AUSTRALIA, 1999, 170 (04) : 165 - 167
  • [22] Pneumococcal virulence factors in community-acquired pneumonia
    Feldman, Charles
    Anderson, Ronald
    CURRENT OPINION IN PULMONARY MEDICINE, 2020, 26 (03) : 222 - 231
  • [23] Controversies in the treatment of pneumococcal community-acquired pneumonia
    Feldman, Charles
    Anderson, Ronald
    FUTURE MICROBIOLOGY, 2006, 1 (03) : 271 - 281
  • [24] Influence of comorbidities on pneumococcal community-acquired pneumonia
    Polverino, Eva
    Cilloniz, Catia
    Gabarrus, Albert
    Amaro, Rosanel
    Domingo, Rebeca
    Sialer, Salvador
    Sellares, Jacobo
    Torresi, Antoni
    Polverino, Eva
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [25] Pneumococcal vaccines and the prevention of community-acquired pneumonia
    Esposito, Susanna
    Principi, Nicola
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2015, 32 : 124 - 129
  • [26] Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia
    Isturiz, Raul E.
    Ramirez, Julio
    Self, Wesley H.
    Grijalva, Carlos G.
    Counselman, Francis L.
    Volturo, Gregory
    Ostrosky-Zeichner, Luis
    Peyrani, Paula
    Wunderink, Richard G.
    Sherwin, Robert
    Overcashi, J. Scott
    Oliva, Senen Pena
    File, Thomas
    Wiemken, Timothy L.
    McLaughlin, John M.
    Pride, Michael W.
    Gray, Sharon
    Alexander, Ronika
    Ford, Kimbal D.
    Jiang, Qin
    Jodar, Luis
    VACCINE, 2019, 37 (25) : 3352 - 3361
  • [27] Procalcitonin and community-acquired pneumonia (CAP) in children
    Giulia, Bivona
    Luisa, Agnello
    Concetta, Scazzone
    Bruna, Lo Sasso
    Chiara, Bellia
    Marcello, Ciaccio
    CLINICA CHIMICA ACTA, 2015, 451 : 215 - 218
  • [28] There is no "CAP" on the importance of community-acquired pneumonia in the ICU
    Shorr, Andrew F.
    Wunderink, Richard G.
    CHEST, 2008, 133 (03) : 590 - 592
  • [29] Osteopontin role in community-Acquired Pneumonia (CAP)
    Sharshar, Ragia
    Ibrahim, Ibrahim
    Mohamed, Ahmed
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [30] Role of virus in community-acquired pneumonia (CAP)
    Simon, Ana
    Panadero, Carolina
    Minchole, Elisa
    Fandos, Sergio
    Lasierra, Ana
    Ruiz, Maria Angeles
    Forcen, Elena
    Moya, Virginia
    Vera, Elisabeth
    Bello, Salvador
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
12345